(Q37183154)

18 August 2017

1 reference

title

Review article: diagnosis and treatment of non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

18 August 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

M K Oh

1

1 reference

18 August 2017

J Winn

series ordinal

2

1 reference

18 August 2017

F Poordad

series ordinal

3

1 reference

18 August 2017

language of work or name

English

0 references

publication date

3 June 2008

1 reference

Alimentary Pharmacology & Therapeutics

18 August 2017

published in

1 reference

18 August 2017

volume

28

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

503-522

1 reference

IRS proteins and the common path to diabetes

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Effect of nutritional counselling on hepatic, muscle and adipose tissue fat content and distribution in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Interim results of a pilot study demonstrating the early effects of the PPAR-gamma ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2008.03752.X

10.1111/J.1365-2036.2008.03752.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference